Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in mild to moderate COVID-19
NCT04467918Phase 3Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Jul 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in coronavirus disease 2019 (COVID-19), sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04467918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467918.